CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor Novo Nordisk, will still be covered under plans managed by CVS Caremark.

Do those on Zepbound have to switch to Wegovy after Caremark drops Zepbound from preferred coverage? What options are there? Here's what to know.

Pharmacy benefit manager CVS Caremark drops Zepbound coverage, estimating 10-15% savings while Eli Lilly offers self-pay programs at $499 monthly ...

The big health insurers Moody's rates now face shrinking profit margins at the Medicaid plans they manage for state ...

CVS Health, owner of Aetna, announced that Aetna will withdraw all Affordable Care Act (ACA) individual and family plans at ...

The coverage change applies to CVS Caremark’s most common formulary template, which represents between 25 and 30 million individuals overall. ... CVS Health said.

The coverage change applies to CVS Caremark’s most common formulary template, which represents between 25 and 30 million individuals overall. ... CVS Health said.

Pharmacy benefit manager CVS Caremark decided to replace Zepbound with Wegovy for use in weight loss starting July 1, despite Zepbound users having more weight loss success.

Over 261,000 people in Virginia have Aetna healthcare...Aetna is under the CVS umbrella and has participated in the ACA ...

NEW YORK, July 14 (Reuters) - President Donald Trump's spending bill is set to raise administrative costs and make managing ...

The California Public Employees’ Retirement System (CalPERS) has a new pharmacy benefits contract with CVS Caremark, the ...

As of July 1, CVS dropped Zepbound from preferred coverage for those covered by its pharmacy benefit manager, Caremark. Novo Nordisk A/S's Wegovy, a semiglutide injectable medicine, is now the ...